Literature DB >> 11595982

Whither infectious diseases consultations? Analysis of 14,005 consultations from a 5-year period.

A M Yinnon1.   

Abstract

During a 5-year period, data from all infectious disease (ID) consultations were recorded in a computerized database, which included 9068 new and 4937 additional consultations. The purpose of these 14,005 consultations was therapy (for 58%), diagnosis (for 13%), both (for 24%), and prophylaxis (for 4%); 51% were performed at the bedside, and the remainder were by discussion (19%) or telephone (30%). Recommendations included the following: initiation, change, or discontinuation of antibiotics (in 46%); performance of diagnostic tests (in 20%) or surgical procedures (in 1%); prophylaxis (in 3%); or no change (in 29%). Analysis of new versus additional consultations revealed significant differences. A new ID consultation was given at a rate of 6.0 consultations per 100 hospitalized patients; the rate per department correlated with the expenditure on antimicrobials per patient admission. During the study period, expenditure on antimicrobials per admission steadily decreased, from $44 in 1995 to $30 in 1999, a 35% reduction. In conclusion, analysis of data from ID consultations enables the ID service to evaluate its activity and to direct efforts to departments with high rates of nosocomial infections, antimicrobial resistance, and/or antimicrobial use.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11595982     DOI: 10.1086/323760

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  20 in total

1.  Cost of infectious diseases.

Authors:  C Ruef
Journal:  Infection       Date:  2002-04       Impact factor: 3.553

2.  Formal adult infectious disease specialist consultations in the outpatient setting at a comprehensive cancer center (1998-2008): diverse and impactful.

Authors:  G Pongas; G Hamilos; K V Rolston; Dimitrios P Kontoyiannis
Journal:  Support Care Cancer       Date:  2010-12-30       Impact factor: 3.603

3.  Inpatient infectious disease consultations requested by surgeons at a comprehensive cancer center.

Authors:  Ichiro Kawamura; Hanako Kurai
Journal:  Support Care Cancer       Date:  2015-03-01       Impact factor: 3.603

4.  Family studies in brucellosis.

Authors:  E J Young
Journal:  Infection       Date:  2008-11-19       Impact factor: 3.553

Review 5.  [The value of clinical infectology].

Authors:  M Battegay; U Flückiger
Journal:  Internist (Berl)       Date:  2005-06       Impact factor: 0.743

6.  Unsolicited post-prescription antibiotic review in surgical and medical wards: factors associated with counselling and physicians' compliance.

Authors:  P Lesprit; C Landelle; C Brun-Buisson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-24       Impact factor: 3.267

7.  Synergy, Salary, and Satisfaction: Benefits of Training in Critical Care Medicine and Infectious Diseases Gleaned From a National Pilot Survey of Dually Trained Physicians.

Authors:  Sameer S Kadri; Chanu Rhee; Gabriela Magda; Jeffrey R Strich; Rongman Cai; Junfeng Sun; Brooke K Decker; Naomi P O'Grady
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

8.  Compliance with recommendations and clinical outcomes for formal and informal infectious disease specialist consultations.

Authors:  E Sellier; J Labarère; S Gennai; G Bal; P François; P Pavese
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-02-11       Impact factor: 3.267

9.  Infectious disease services: a survey from four university hospitals in Germany.

Authors:  Siegbert Rieg; Florian Hitzenbichler; Stefan Hagel; Isabelle Suarez; Florian Kron; Bernd Salzberger; Mathias Pletz; Winfried V Kern; Gerd Fätkenheuer; Norma Jung
Journal:  Infection       Date:  2018-08-17       Impact factor: 3.553

10.  An evaluation of 1 year of advice calls to a tropical and infectious disease referral Centre.

Authors:  Tom Wingfield; Mike Bj Beadsworth; Nicholas J Beeching; Susan Gould; Luke Mair; Emmanuel Nsutebu
Journal:  Clin Med (Lond)       Date:  2020-07       Impact factor: 2.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.